ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BLCO Bausch plus Lomb Corporation

14.85
0.21 (1.43%)
Apr 23 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 352,034
Bid Price
Ask Price
News -
Day High 15.01

Low
13.62

52 Week Range

High
21.95

Day Low 14.635
Company Name Stock Ticker Symbol Market Type
Bausch plus Lomb Corporation BLCO NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.21 1.43% 14.85 16:06:39
Open Price Low Price High Price Close Price Prev Close
14.67 14.635 15.01 14.85 14.64
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,551 352,034 $ 14.89 $ 5,240,453 - 13.62 - 21.95
Last Trade Time Type Quantity Stock Price Currency
19:00:00 24,607 $ 14.85 USD

Bausch plus Lomb Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
7.13B 350.99M - 4.15B -260M -0.74 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Bausch plus Lomb News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BLCO Message Board. Create One! See More Posts on BLCO Message Board See More Message Board Posts

Historical BLCO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week14.3015.0113.8914.38444,7800.553.85%
1 Month16.6117.52513.8015.21557,641-1.76-10.60%
3 Months14.5017.69513.6215.53473,5010.352.41%
6 Months16.7817.69513.6215.57513,399-1.93-11.50%
1 Year17.1721.9513.6216.99486,322-2.32-13.51%
3 Years18.5021.9512.2016.45619,845-3.65-19.73%
5 Years18.5021.9512.2016.45619,845-3.65-19.73%

Bausch plus Lomb Description

Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries.

Your Recent History

Delayed Upgrade Clock